** Hera Med's Australia-listed shares rise as much as 4.8% to A$0.022, their highest level since Sept 12

** Israel-based maternity technology co signs letter of intent with Founda Health to enter into strategic partnership

** Says it will use Founda's platform to integrate its HeraCARE solution with electronic health records within the hospital systems and ensure better service to expectant mothers

** Stock had fallen 9.5% this year, as of last close

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))